Scotiabank Cuts Biodesix (NASDAQ:BDSX) Price Target to $2.00
Biodesix (NASDAQ:BDSX – Free Report) had its price objective trimmed by Scotiabank from $3.00 to $2.00 in a research note published on Wednesday morning,Benzinga reports. The brokerage currently has a sector outperform rating on the stock. A number of other research firms have also recently weighed in on BDSX. Canaccord Genuity Group decreased their price […]
Biodesix (NASDAQ:BDSX – Free Report) had its price objective trimmed by Scotiabank from $3.00 to $2.00 in a research note published on Wednesday morning,Benzinga reports. The brokerage currently has a sector outperform rating on the stock. A number of other research firms have also recently weighed in on BDSX. Canaccord Genuity Group decreased their price […]
